Skip to main content
. 2024 Jun 25;79(5):1153–1161. doi: 10.1093/cid/ciae338

Figure 3.

Figure 3.

Effect of adjunctive rifampicin in Staphylococcus aureus bacteremia (SAB) subphenotypes. Comparison of outcomes of patients randomized to placebo or adjunctive rifampicin when SAB subphenotypes were considered separately. Treatment outcomes within each subphenotype were compared using the Fisher exact test. Because 2 comparisons were made within each subphenotype, the significance level was set at 0.025 (α=0.05, n = 2).